Antagonistic selective binding agents of osteoprotegerin binding protein
CA 2400929 C · Owner: Deshpande, Rajendra V. · Inventors: Sullivan, John Kevin; Hitz, Anna; Deshpande, Rajendra V.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Selective binding agents of osteoprotegerin binding protein (OPGbp) are provided by the invention. More particularly the invention provides for , antibodies and antigen binding domains which selectively bind to OPGbp and may be used to prevent or treat conditions relating to loss of bone mass. Nucleic acid molecules encoding said antibodies and antigen binding domains and , expression vectors and host cells for the production of same are also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 23, 2001 and granted May 31, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 23, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 23, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.